Market Research Logo

Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application, By Product Type, By Region, By Country (2018 Edition): Forecast to 2022 

Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application, By Product Type, By Region, By Country (2018 Edition): Forecast to 2022 

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global I.V. Iron Drugs Market by Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others), By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Brazil, South Africa).

Over the recent years, the global Intravenous (IV) Iron Drug industry has been driven by the rising high prevalence of Iron Deficiency with unfulfilled need, rising awareness, growing prevalence of diseases leading to severe Iron Deficiency and increasing healthcare expenditure in emerging economies. Globally, the growth in IV Iron drug market is driven by growing middle class population group demanding better drugs to improve lifestyle.

According to Azoth Analytics research report, “Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others), By Product Type (Ferric Carboxymaltose, Iron Sucrose, Iron Dextran, Others) - By Region, By Country (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 11.19% by value during 2017 – 2022, chiefly driven by increase in healthcare spending and rising prevalence of diseases with Iron deficiency, emerging second & third generation IV Iron drugs and growing middle class income group coupled with rising health consciousness.

Among the therapeutic application type, nephrology accounts for the major market share and anticipated to witness significant growth rate during the forecast period. Among the regions, Asia Pacific is predicted to advance at the highest rate, mainly driven by large population suffering with Iron Deficiency and unfulfilled need, improving access to healthcare, changing lifestyle and expanding middle class income group.

The report titled, “Global Intravenous (IV) Iron Drugs Market: Analysis By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others), By Product Type (Ferric Carboxymaltose, Iron Sucrose, Iron Dextran, Others) - By Region, By Country (2017-2022)” has covered and analysed the potential of IV Iron Drug Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global IV Iron Drug market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)

  • Global IV Iron Drug Market, By Value
  • By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
  • By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value
Regional Markets – North America, Europe, APAC, and ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
  • By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
  • By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value
Country Analysis - United States, Canada, United Kingdom, Germany, France, China, India, Japan, Brazil and South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
  • By Therapeutic Application (Nephrology, Gynecology & Obstetrics, Gastroenterology, Oncology, Cardiology, Others); By Value
  • By Product Type (Ferric carboxymaltose, Iron Sucrose, Iron Dextran and Others), By Value
Other Report Highlights
  • Market Dynamics – Trends, Drivers, Challenges, Policy and Regulation
  • Company Analysis – Galenica; AMAG Pharmaceuticals, Inc; PHARMACOSMOS A/S; Allergan PLC; DAIICHI SANKYO COMPANY, LIMITED; NIPPON SHINYAKU CO., LTD and Sanofi
Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
3.1. Asia Pacific Region to witness the fastest growth for I.V. Iron drug in the forecast period
3.2. Oncology & cardiology segments are witnessing fastest growth
Table 1: Causes of premature (under age 70) NCD mortality, 2017 (%)
4. I.V. Iron Drug Market Outlook
Table A: Available I.V. Iron formulations approved for use throughout the world
5. Global I.V. Iron Drug Market: Growth and Forecast
5.1. I.V. Iron Drug Market, By Value (2012-2016)
Table 2: Global I.V. Iron Drug Market Size, By Value, 2012-2016 (USD Million)
Table 3: World Population 65 Years & Above (% of Total), 2012-2016
Table 4: Life Expectancy at birth rate (Years), 2012-2015
Table 5: Global Life expectancy at birth, total (years) 2012 -2015
Table 6: World Female Population, 2012-2016
Table 7: Global Healthcare Expenditure, 2012-2016 (In Trillion)
Table 8: Global Potential Patients Numbers, All Indications 2017 (In Million)
5.2. I.V. Iron Drug Market, By Value (2017-2022)
Table 9: Global I.V. Iron Drug Market Size, By Value, Forecast, 2017-2022 (USD Million)
5.3. Global I.V. Iron Drug & Market - By Therapeutic Application, By Value
5.3.1. I.V. Iron Drug, By Value, % (2016)
Table 10: Global I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
5.3.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 11: Global I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
5.4. Global I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 12: Global I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
Table 13: Worldwide Dialysis Patients, Numbers (In Million), 2010, 2015, 2020
5.4.1. Nephrology, By Value (2012-2022)
5.4.2. Gynecology & Obstetrics, By Value (2012-2022)
5.4.3. Gastroenterology, By Value (2012-2022)
5.4.4. Oncology, By Value (2012-2022)
5.4.5. Cardiology, By Value (2012-2022)
5.4.6. Others, By Value (2012-2022)
5.5. North America I.V. Iron Drug Market- By Product Type, By Value, (2012-2022)
Table 14: Global I.V. Iron Drug Market- By Product Type, By Value, 2012-2022 (USD Million)
Table 15: Global I.V. Iron Drug Market- By Product Type, By Value, 2012-2022 (USD Million)
5.5.1. Ferric carboxymaltose, By Value (2012-2022)
5.5.2. Iron Sucrose, By Value (2012-2022)
5.5.3. Iron Dextran
5.5.4. Others
6. North America I.V. Iron Drug Market: Growth and Forecast
6.1. I.V. Iron Drug Market, By Value (2012-2016)
Table 16: North America I.V. Iron Drug Market Size, By Value, 2012-2016 (USD Million)
Table 17: North America Population 65 Years & Above (% of Total), 2012-2016
Table 18: North America Life Expectancy at birth rate (Years), 2012-2015
Table 19: North America Women Population, 2012-2016
Table 20: North America, Per Capita Healthcare Expenditure, 2012-2014 (In USD)
Table 21: Population aged 65 & above, 2012-2016 (% of total)
6.2. I.V. Iron Drug Market, By Value (2017-2022)
Table 22: North America I.V. Iron Drug Market Size, By Value, Forecast, 2017-2022 (USD Million)
6.3. North America I.V. Iron Drug & Market - By Therapeutic Application, By Value
6.3.1. I.V. Iron Drug, By Value, % (2016)
Table 23: North America I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
6.3.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 24: North America I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
6.4. North America I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 25: North America I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
6.4.1. Nephrology, By Value (2012-2022)
6.4.2. Gynecology & Obstetrics, By Value (2012-2022)
6.4.3. Gastroenterology, By Value (2012-2022)
6.4.4. Oncology, By Value (2012-2022)
6.4.5. Cardiology, By Value (2012-2022)
6.4.6. Others, By Value (2012-2022)
6.5. North America I.V. Iron Drug Market- By Product Type, By Value, (2012-2022)
Table 26: North America I.V. Iron Drug Market - By Product Type, By Value, 2012-2022 (USD Million)
6.5.1. Ferric carboxymaltose, By Value (2012-2022)
6.5.2. Iron Sucrose, By Value (2012-2022)
6.5.3. Iron Dextran
6.5.4. Others
6.6. North America I.V. Iron Drug Market: Country Analysis (U.S., Canada)
6.6.1. North America I.V. Iron Drug Market, Country Share, 2012-2016 (% of Total)
Table 27: North America I.V. Iron Drug Market, Country Share, 2016 (% of Total)
6.6.2. North America I.V. Iron Drug Market, Country Share, 2017-2022 (% of Total)
Table 28: North America I.V. Iron Drug Market, Country Share, 2022 (% of Total)
6.7. U.S. I.V. Iron Drug Market: Growth and Forecast
6.7.1. U.S. I.V. Iron Drug Market, By Value (2012-2016)
Table 29: U.S. I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
6.7.2. U.S. I.V. Iron Drug Market, By Value (2017-2022)
Table 29: U.S. I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 30: U.S. Population 65 Years & Above (% of Total), 2012-2016
Table 31: U.S. Life Expectancy at birth rate (Years), 2012-2015
Table 32: U.S. Women Population, 2012-2016
Table 33: U.S. Per Capita Healthcare Expenditure, 2012-2014 (In Trillion)
Table 34: United States I.V. Iron Drug Market- By Product Type, By Value, 2012-2022 (USD Million)
6.8. U.S. I.V. Iron Drug & Market - By Therapeutic Application, By Value
6.8.1. I.V. Iron Drug, By Value, % (2016)
Table 35: U.S. I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
6.8.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 36: U.S. I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
6.9. U.S. I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 37: U.S. I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
6.9.1. Nephrology, By Value (2012-2022)
6.9.2. Gynecology & Obstetrics, By Value (2012-2022)
6.9.3. Gastroenterology, By Value (2012-2022)
6.9.4. Oncology, By Value (2012-2022)
6.9.5. Cardiology, By Value (2012-2022)
6.9.6. Others, By Value (2012-2022)
6.10. Canada I.V. Iron Drug Market: Growth and Forecast
6.10.1. Canada I.V. Iron Drug Market, By Value (2012-2016)
Table 38: Canada I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
6.10.2. Canada I.V. Iron Drug Market, By Value (2017-2022)
Table 38: Canada I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 39: Canada Population 65 Years & Above (% of Total), 2012-2016
Table 40: Canada Life Expectancy at birth rate (Years), 2012-2015
Table 41: Canada Women Population, 2012-2016
Table 42: End Stage Kidney Disease patients by Age group, 2012-2015 (Numbers)
Table 43: Prevalent end-stage kidney disease patients by age group, Canada (excluding Quebec), 2012-2015 (Numbers)
Table 44: Prevalence rate for patients on dialysis (Excluding Quebec), 2012-2015
Table 45: Prevalent rate for patients on dialysis or with a functioning transplant in Canada (excluding Quebec), 2012-2015
6.11. Canada I.V. Iron Drug & Market - By Therapeutic Application, By Value
6.11.1. I.V. Iron Drug, By Value, % (2016)
Table 46: Canada I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
6.11.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 47: Canada I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
6.12. Canada I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 48: Canada I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
6.12.1. Nephrology, By Value (2012-2022)
6.12.2. Gynecology & Obstetrics, By Value (2012-2022)
6.12.3. Gastroenterology, By Value (2012-2022)
6.12.4. Oncology, By Value (2012-2022)
6.12.5. Cardiology, By Value (2012-2022)
6.12.6. Others, By Value (2012-2022)
7. Europe I.V. Iron Drug Market: Growth and Forecast
7.1. I.V. Iron Drug Market, By Value (2012-2016)
Table 49: Europe I.V. Iron Drug Market Size, By Value, 2012-2016 (USD Million)
Table 50: European Union Population 65 Years & Above (% of Total), 2012-2016
Table 51: European Union Life Expectancy at birth rate (Years), 2012-2015
Table 52: European Union Women Population, 2012-2016
Table 53: European Union, Per Capita Healthcare Expenditure, 2012-2014 (In USD)
Table 54: European Potential Patients Numbers, All Indications 2017 (In Million)
7.2. I.V. Iron Drug Market, By Value (2017-2022)
Table 55: Europe I.V. Iron Drug Market Size, By Value, Forecast, 2017-2022 (USD Million)
7.3. Europe I.V. Iron Drug & Market - By Therapeutic Application, By Value
7.3.1. I.V. Iron Drug, By Value, % (2016)
Table 56: Europe I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
7.3.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 57: Europe I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
7.4. Europe I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 58: Europe I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
7.4.1. Nephrology, By Value (2012-2022)
7.4.2. Gynecology & Obstetrics, By Value (2012-2022)
7.4.3. Gastroenterology, By Value (2012-2022)
7.4.4. Oncology, By Value (2012-2022)
7.4.5. Cardiology, By Value (2012-2022)
7.4.6. Others, By Value (2012-2022)
7.5. Europe I.V. Iron Drug Market- By Product Type, By Value, (2012-2022)
Table 59: Europe I.V. Iron Drug Market - By Product Type, By Value, 2012-2022, (USD Million)
Table 60: Europe I.V. Iron Drug Market- By Product Type, By Value, 2012-2022 (USD Million)
7.5.1. Ferric carboxymaltose, By Value (2012-2022)
7.5.2. Iron Sucrose, By Value (2012-2022)
7.5.3. Iron Dextran
7.5.4. Others
7.6. Europe I.V. Iron Drug Market: Country Analysis (U.K., Germany, France, Rest of Europe)
7.6.1. Europe I.V. Iron Drug Market, Country Share, 2012-2016 (% of Total)
Table 61: Europe I.V. Iron Drug Market, Country Share, 2016 (% of Total)
7.6.2. Europe I.V. Iron Drug Market, Country Share, 2017-2022 (% of Total)
Table 62: Europe I.V. Iron Drug Market, Country Share, 2022 (% of Total)
7.7. U.K. I.V. Iron Drug Market: Growth and Forecast
7.7.1. U.K. I.V. Iron Drug Market, By Value (2012-2016)
Table 63: U.K. I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
7.7.2. U.K. I.V. Iron Drug Market, By Value (2017-2022)
Table 63: U.K. I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 64: U.K. Population 65 Years & Above (% of Total), 2012-2016
Table 65: U.K. Life Expectancy at birth rate (Years), 2012-2015
Table 66: U.K. Women Population, 2012-2016
Table 67: U.K., Per Capita Healthcare Expenditure, 2012-2014 (In USD)
7.8. U.K. I.V. Iron Drug & Market - By Therapeutic Application, By Value
7.8.1. I.V. Iron Drug, By Value, % (2016)
Table 68: U.K. I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
7.8.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 69: U.K. I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
7.9. U.K. I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 70: U.K. I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
Table B: Percentage of patients receiving chemotherapy as a part of their primary treatment, Persons, all ages, England 2013-2014
7.9.1. Nephrology, By Value (2012-2022)
7.9.2. Gynecology & Obstetrics, By Value (2012-2022)
7.9.3. Gastroenterology, By Value (2012-2022)
7.9.4. Oncology, By Value (2012-2022)
7.9.5. Cardiology, By Value (2012-2022)
7.9.6. Others, By Value (2012-2022)
7.10. Germany I.V. Iron Drug Market: Growth and Forecast
7.10.1. Germany I.V. Iron Drug Market, By Value (2012-2016)
Table 71: Germany I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
7.10.2. Germany I.V. Iron Drug Market, By Value (2017-2022)
Table 71: Germany I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 72: Germany Population 65 Years & Above (% of Total), 2012-2016
Table 73: Germany Life Expectancy at birth rate (Years), 2012-2015
Table 74: Germany Women Population, 2012-2016
Table 75: Germany Per Capita Healthcare Expenditure, 2012 - 2014 (In USD)
7.11. Germany I.V. Iron Drug & Market - By Therapeutic Application, By Value
7.11.1. I.V. Iron Drug, By Value, % (2016)
Table 76: Germany I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
7.11.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 77: Germany I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
7.12. Germany I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 78: Germany I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
7.12.1. Nephrology, By Value (2012-2022)
7.12.2. Gynecology & Obstetrics, By Value (2012-2022)
7.12.3. Gastroenterology, By Value (2012-2022)
7.12.4. Oncology, By Value (2012-2022)
7.12.5. Cardiology, By Value (2012-2022)
7.12.6. Others, By Value (2012-2022)
7.13. France I.V. Iron Drug Market: Growth and Forecast
7.13.1. France I.V. Iron Drug Market, By Value (2012-2016)
Table 79: France I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
7.13.2. France I.V. Iron Drug Market, By Value (2017-2022)
Table 79: France I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 80: France Population 65 Years & Above (% of Total), 2012-2016
Table 81: France Life Expectancy at birth rate (Years), 2012-2015
Table 82: France Women Population, 2012-2016
Table 83: France Per Capita Healthcare Expenditure, 2012-2014 (In USD)
7.14. France I.V. Iron Drug & Market - By Therapeutic Application, By Value
7.14.1. I.V. Iron Drug, By Value, % (2016)
Table 84: France I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
7.14.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 85: France I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
7.15. France I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 86: France I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
7.15.1. Nephrology, By Value (2012-2022)
7.15.2. Gynecology & Obstetrics, By Value (2012-2022)
7.15.3. Gastroenterology, By Value (2012-2022)
7.15.4. Oncology, By Value (2012-2022)
7.15.5. Cardiology, By Value (2012-2022)
7.15.6. Others, By Value (2012-2022)
7.16. Rest of Europe I.V. Iron Drug Market: Growth and Forecast
7.16.1. Rest of Europe I.V. Iron Drug Market, By Value (2012-2016)
Table 87: Rest of Europe I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
7.16.2. Rest of Europe I.V. Iron Drug Market, By Value (2017-2022)
Table 87: Rest of Europe I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
8. Asia Pacific I.V. Iron Drug Market: Growth and Forecast
8.1. I.V. Iron Drug Market, By Value (2012-2016)
Table 88: Asia-Pacific I.V. Iron Drug Market Size, By Value, 2012-2016 (USD Million)
8.2. I.V. Iron Drug Market, By Value (2017-2022)
Table 89: Asia-Pacific I.V. Iron Drug Market Size, By Value, Forecast, 2017-2022 (USD Million)
8.3. Asia Pacific I.V. Iron Drug & Market - By Therapeutic Application, By Value
8.3.1. I.V. Iron Drug, By Value, % (2016)
Table 90: Asia-Pacific I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
8.3.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 91: Asia-Pacific I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
8.4. Asia Pacific I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 92: Asia-Pacific I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
8.4.1. Nephrology, By Value (2012-2022)
8.4.2. Gynecology & Obstetrics, By Value (2012-2022)
8.4.3. Gastroenterology, By Value (2012-2022)
8.4.4. Oncology, By Value (2012-2022)
8.4.5. Cardiology, By Value (2012-2022)
8.4.6. Others, By Value (2012-2022)
8.5. Asia Pacific I.V. Iron Drug Market- By Product Type, By Value, (2012-2022)
Table 93: Asia-Pacific I.V. Iron Drug Market - By Product Type, By Value, 2012-2022 (USD Million)
8.5.1. Ferric carboxymaltose, By Value (2012-2022)
8.5.2. Iron Sucrose, By Value (2012-2022)
8.5.3. Iron Dextran
8.5.4. Others
8.6. Asia Pacific I.V. Iron Drug Market: Country Analysis (Japan, China, India, Rest of Asia-Pacific)
8.6.1. Asia Pacific I.V. Iron Drug Market, Country Share, 2012-2016 (% of Total)
Table 94: Asia-Pacific I.V. Iron Drug Market, Country Share, 2016 (% of Total)
8.6.2. Asia Pacific I.V. Iron Drug Market, Country Share, 2017-2022 (% of Total)
Table 95: Asia-Pacific I.V. Iron Drug Market, Country Share, 2022 (% of Total)
8.7. Japan I.V. Iron Drug Market: Growth and Forecast
8.7.1. Japan I.V. Iron Drug Market, By Value (2012-2016)
Table 96: Japan I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
8.7.2. Japan I.V. Iron Drug Market, By Value (2017-2022)
Table 96: Japan I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 97: Japan Population 65 Years & Above (% of Total), 2012-2016
Table 98: Japan Life Expectancy at birth rate (Years), 2012-2015
Table 99: Japan, Per Capita Healthcare Expenditure, 2012-2014 (In USD)
8.8. Japan I.V. Iron Drug & Market - By Therapeutic Application, By Value
8.8.1. I.V. Iron Drug, By Value, % (2016)
Table 100: Japan I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
8.8.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 101: Japan I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
8.9. Japan I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 102: Japan I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
8.9.1. Nephrology, By Value (2012-2022)
8.9.2. Gynecology & Obstetrics, By Value (2012-2022)
8.9.3. Gastroenterology, By Value (2012-2022)
8.9.4. Oncology, By Value (2012-2022)
8.9.5. Cardiology, By Value (2012-2022)
8.9.6. Others, By Value (2012-2022)
8.10. China I.V. Iron Drug Market: Growth and Forecast
8.10.1. China I.V. Iron Drug Market, By Value (2012-2016)
Table 103: China I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
8.10.2. China I.V. Iron Drug Market, By Value (2017-2022)
Table 103: China I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 104: China Population 65 Years & Above (% of Total), 2012-2016
Table 105: China Life Expectancy at birth rate (Years), 2012-2015
Table 106: China Women Population, 2012-2016
Table 106: China Women Population, 2012-2016
8.11. China I.V. Iron Drug & Market - By Therapeutic Application, By Value
8.11.1. I.V. Iron Drug, By Value, % (2016)
Table 108: China I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
8.11.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 109: China I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
8.12. China I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 110: China I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
Table 111: Registered Number Dialysis patients in China (In ten thousands), 2012-2016
8.12.1. Nephrology, By Value (2012-2022)
8.12.2. Gynecology & Obstetrics, By Value (2012-2022)
8.12.3. Gastroenterology, By Value (2012-2022)
8.12.4. Oncology, By Value (2012-2022)
8.12.5. Cardiology, By Value (2012-2022)
8.12.6. Others, By Value (2012-2022)
8.13. India I.V. Iron Drug Market: Growth and Forecast
8.13.1. India I.V. Iron Drug Market, By Value (2012-2016)
Table 112: India I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
8.13.2. India I.V. Iron Drug Market, By Value (2017-2022)
Table 112: India I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 113: India Population 65 Years & Above (% of Total), 2012-2016
Table 114: India Life Expectancy at birth rate (Years), 2012-2015
Table 115: India Women Population, 2012-2016
Table 116: India Per Capita Healthcare Expenditure, 2012-2014 (In USD)
8.14. India I.V. Iron Drug & Market - By Therapeutic Application, By Value
8.14.1. I.V. Iron Drug, By Value, % (2016)
Table 117: India I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
8.14.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 118: India I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
8.15. India I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 119: India I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
8.15.1. Nephrology, By Value (2012-2022)
8.15.2. Gynecology & Obstetrics, By Value (2012-2022)
8.15.3. Gastroenterology, By Value (2012-2022)
8.15.4. Oncology, By Value (2012-2022)
8.15.5. Cardiology, By Value (2012-2022)
8.15.6. Others, By Value (2012-2022)
8.16. Rest of Asia Pacific I.V. Iron Drug Market: Growth and Forecast
8.16.1. Rest of Asia Pacific I.V. Iron Drug Market, By Value (2012-2016)
Table 120: Rest of Asia-Pacific I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
8.16.2. Rest of Asia Pacific I.V. Iron Drug Market, By Value (2017-2022)
Table 120: Rest of Asia-Pacific I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
9. ROW I.V. Iron Drug Market: Growth and Forecast
9.1. I.V. Iron Drug Market, By Value (2012-2016)
Table 121: ROW I.V. Iron Drug Market Size, By Value, 2012-2016 (USD Million)
9.2. I.V. Iron Drug Market, By Value (2017-2022)
Table 122: ROW I.V. Iron Drug Market Size, By Value, Forecast, 2017-2022 (USD Million)
9.3. ROW I.V. Iron Drug & Market - By Therapeutic Application, By Value
9.3.1. I.V. Iron Drug, By Value, % (2016)
Table 123: ROW I.V. Iron Drug Market Size, By Therapeutic Application, 2016 (%)
9.3.2. I.V. Iron Drug, By Value, % (Forecast 2022F)
Table 124: ROW I.V. Iron Drug Market Size, By Therapeutic Application, 2022 (%)
9.4. ROW I.V. Iron Drug & Market- By Therapeutic Application, By Value (2012-2022)
Table 125: ROW I.V. Iron Drug Market- By Therapeutic Application, By Value 2012-2022 (USD Million)
9.4.1. Nephrology, By Value (2012-2022)
9.4.2. Gynecology & Obstetrics, By Value (2012-2022)
9.4.3. Gastroenterology, By Value (2012-2022)
9.4.4. Oncology, By Value (2012-2022)
9.4.5. Cardiology, By Value (2012-2022)
9.4.6. Others, By Value (2012-2022)
9.5. ROW I.V. Iron Drug Market- By Product Type, By Value, (2012-2022)
Table 126: ROW I.V. Iron Drug Market - By Product Type, By Value, 2012-2022 (USD Million)
9.5.1. Ferric carboxymaltose, By Value (2012-2022)
9.5.2. Iron Sucrose, By Value (2012-2022)
9.5.3. Iron Dextran
9.5.4. Others
9.6. ROW I.V. Iron Drug Market: Country Analysis (Brazil, South Africa)
9.6.1. ROW I.V. Iron Drug Market, Country Share, 2012-2016 (% of Total)
Table 127: ROW I.V. Iron Drug Market, Country Share, 2016 (% of Total)
9.6.2. ROW I.V. Iron Drug Market, Country Share, 2017-2022 (% of Total)
Table 128: ROW I.V. Iron Drug Market, Country Share, 2022 (% of Total)
9.7. Brazil I.V. Iron Drug Market: Growth and Forecast
9.7.1. Brazil I.V. Iron Drug Market, By Value (2012-2016)
Table 129: Brazil I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
9.7.2. Brazil I.V. Iron Drug Market, By Value (2017-2022)
Table 129: Brazil I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 130: Brazil Population 65 Years & Above (% of Total), 2012-2016
Table 131: Brazil Life Expectancy at birth rate (Years), 2012-2015
Table 132: Brazil Women Population, 2012-2016
Table 133: Brazil, Per Capita Healthcare Expenditure, 2012-2014 (In USD)
9.8. South Africa I.V. Iron Drug Market: Growth and Forecast
9.8.1. South Africa I.V. Iron Drug Market, By Value (2012-2016)
Table 134: South Africa I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
9.8.2. South Africa I.V. Iron Drug Market, By Value (2017-2022)
Table 134: South Africa I.V. Iron Drug Market Size, By Value, 2012-2022 (USD Million)
Table 135: South Africa Population 65 Years & Above (% of Total), 2012-2016
Table 136: South Africa Life Expectancy at birth rate (Years), 2012-2015
Table 137: South Africa Women Population, 2012-2016
Table 138: South Africa Per Capita Healthcare Expenditure, 2012-2014 (In USD)
10. Market Dynamics 10.1. Increasing Geriatric Population Worldwide
Table 139: Percentage aged 60 years and over, (2000, 2015, 2030, 2050)
10.2. Increasing awareness about the Iron Deficiency diseases
10.3. Rising healthcare expenditure worldwide
Table 140: Global Healthcare Expenditure, 2012-2016 (In Trillion)
10.4. Increasing number of dialysis patients
Table 141: Global Dialysis Patients, By Dialysis, 2016, (% Share)
Table 142: Global Dialysis Patients, 2012 -2016, Million
10.5. Increasing Life Expectancy
Table 143: Global Life expectancy at birth, total (years) 1990-2100
11. Market Restraints
12. SWOT Analysis –Heart Valve Devices Market
13. Porter’s Five Forces Analysis – Heart Valve Devices Market
14. Policy and Regulations
15. Company Profile
15.1. Galenica
Table 144: Net Sales, By Business Unit, 2016 (%)
Table 145: Net Sales, By Region, 2016 (%)
Table 146: Revenue, 2013-2016 (USD Million)
15.2. AMAG Pharmaceuticals, Inc,
Table 147: AMAG Pharmaceuticals, Inc. Revenue (USD Million) 2012-2016
Table 148: Net Sales, By Business Unit, 2016 (%)
15.3. PHARMACOSMOS A/S,
15.4. Allergan PLC
Table 149: AMAG Pharmaceuticals, Inc. Revenue (USD Million) 2014-2016
Table 150: Net Sales, By Business Unit, 2016 (%)
15.5. DAIICHI SANKYO COMPANY, LIMITED,
Table 151: DAIICHI SANKYO Revenue, By Business segment, 2016 (%)
Table 152: DAIICHI SANKYO JAPAN BUSINESS, By Revenues, By Business segment, 2016 (%)
Table 153: DAIICHI SANKYO COMPANY, LIMITED Revenue (USD Million) 2012-2016
15.6. NIPPON SHINYAKU CO., LTD,
Table 154: NIPPON SHINYAKU CO., LTD, By Revenues, By Business segment, % Share Year Ending March 31st 2017 (%)
Table 155: NIPPON SHINYAKU CO., LTD Revenue (USD Million) 2013-2017, Year Ending March 31st 2017
Table 156: NIPPON SHINYAKU CO., LTD Revenue, By Geography, % Share, Year Ending March 31st 2017
Table 157: NIPPON SHINYAKU CO., LTD, R & D Expenses, 2016 (%)
15.7. Sanofi
Table 158: Sanofi Revenue, By Business segment, 2016 (%)
Table 159: Sanofi BUSINESS, By, Revenues, By Business segment, 2016 (%)
Table 160: Sanofi Revenue (USD Million) 2012-2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report